Related references
Note: Only part of the references are listed.Phase 2 Trial of Leuprorelin in Patients with Spinal and Bulbar Muscular Atrophy
Haruhiko Banno et al.
ANNALS OF NEUROLOGY (2009)
Pathogenic Mechanisms of a Polyglutamine-mediated Neurodegenerative Disease, Spinocerebellar Ataxia Type 1
Huda Y. Zoghbi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
The promises and pitfalls of RNA-interference-based therapeutics
Daniela Castanotto et al.
NATURE (2009)
Allele-specific silencing of mutant huntingtin and ataxin-3 genes by targeting expanded CAG repeats in mRNAs
Jiaxin Hu et al.
NATURE BIOTECHNOLOGY (2009)
Rhes, a Striatal Specific Protein, Mediates Mutant-Huntingtin Cytotoxicity
Srinivasa Subramaniam et al.
SCIENCE (2009)
Polyglutamine expansion reduces the association of TATA-binding protein with DNA and induces DNA binding-independent neurotoxicity
Meyer J. Friedman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Opposing effects of polyglutamine expansion on native protein complexes contribute to SCA1
Janghoo Lim et al.
NATURE (2008)
Soluble polyglutamine oligomers formed prior to inclusion body formation are cytotoxic
Toshiaki Takahashi et al.
HUMAN MOLECULAR GENETICS (2008)
Polyglutamine domain modulates the TBP-TFIIB interaction: implications for its normal function and neurodegeneration
Meyer J. Friedman et al.
NATURE NEUROSCIENCE (2007)
A Mutant ataxin-3 fragment N-terminal to amino acid 190 disease-like transgenic mice
Veronica F. Colomer Gould et al.
NEUROBIOLOGY OF DISEASE (2007)
Transvascular delivery of small interfering RNA to the central nervous system
Priti Kumar et al.
NATURE (2007)
Akt blocks ligand binding and protects against expanded polyglutamine androgen receptor toxicity
Isabella Palazzolo et al.
HUMAN MOLECULAR GENETICS (2007)
Huntingtin facilitates dynein/dynactin-mediated vesicle transport
Juliane P. Caviston et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
OGG1 initiates age-dependent CAG trinucleotide expansion in somatic cells
Irina V. Kovtun et al.
NATURE (2007)
CHIP overexpression reduces mutant androgen receptor protein and ameliorates phenotypes of the spinal and bulbar muscular atrophy transgenic mouse model
Hiroaki Adachi et al.
JOURNAL OF NEUROSCIENCE (2007)
Proteome analysis of soluble nuclear proteins reveals that HMGB1/2 suppress genotoxic stress in polyglutamine diseases
Mei-Ling Qi et al.
NATURE CELL BIOLOGY (2007)
A toxic monomeric conformer of the polyglutamine protein
Yoshitaka Nagai et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2007)
CREB-binding protein modulates repeat instability in a Drosophila model for polyQ disease
Joonil Jung et al.
SCIENCE (2007)
Soluble androgen receptor oligomers underlie pathology in a mouse model of spinobulbar muscular atrophy
Mei Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Ubiquitin-conjugating enzyme E2-25K increases aggregate formation and cell death in polyglutamine diseases
Remko de Pril et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2007)
A century-old debate on protein aggregation and neurodegeneration enters the clinic
Peter T. Lansbury et al.
NATURE (2006)
Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases
Michael T. Lin et al.
NATURE (2006)
The chaperonin TRiC controls polyglutamine aggregation and toxicity through subunit-specific interactions
Stephen Tam et al.
NATURE CELL BIOLOGY (2006)
Cytosolic chaperonin prevents polyglutamine toxicity with altering the aggregation state
Akira Kitamura et al.
NATURE CELL BIOLOGY (2006)
Chaperonin TRiC promotes the assembly of polyQ expansion proteins into nontoxic oligomers
Christian Behrends et al.
MOLECULAR CELL (2006)
CHIP protects from the neurotoxicity of expanded and wild-type ataxin-1 and promotes their ubiquitination and degradation
Ismael Al-Ramahi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Polyglutamine proteins at the pathogenic threshold display neuron-specific aggregation in a pan-neuronal Caenorhabditis elegans model
Heather R. Brignull et al.
JOURNAL OF NEUROSCIENCE (2006)
PML clastosomes prevent nuclear accumulation of mutant ataxin-7 and other polyglutamine proteins
Alexandre Janer et al.
JOURNAL OF CELL BIOLOGY (2006)
Biologically active molecules that reduce polyglutamine aggregation and toxicity
Urvee A. Desai et al.
HUMAN MOLECULAR GENETICS (2006)
Palmitoylation of huntingtin by HIP14 is essential for its trafficking and function
Anat Yanai et al.
NATURE NEUROSCIENCE (2006)
Proteolytic cleavage of polyglutamine-expanded ataxin-3 is critical for aggregation and sequestration of non-expanded ataxin-3
A Haacke et al.
HUMAN MOLECULAR GENETICS (2006)
Interaction of huntingtin fragments with brain membranes -: clues to early dysfunction in Huntington's disease
J Suopanki et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Evidence that Perutz's double-β-stranded subunit structure for β-amyloids also applies to their channel-forming structures in membranes
SJ Singer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
CHIP suppresses polyglutamine aggregation and toxicity in vitro and in vivo
VM Miller et al.
JOURNAL OF NEUROSCIENCE (2005)
17-AAG, an Hsp90 inhibitor, ameliorates polyglutamine-mediated motor neuron degeneration
M Waza et al.
NATURE MEDICINE (2005)
Purification of neuronal inclusions of patients with Huntington's disease reveals a broad range of N-terminal fragments of expanded huntingtin and insoluble polymers
G Hoffner et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Diseases of unstable repeat expansion: Mechanisms and common principles
JR Gatchel et al.
NATURE REVIEWS GENETICS (2005)
Suppression of Huntington's disease pathology in Drosophila by human single-chain Fv antibodies
WJ Wolfgang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Polyglutamine-expanded ataxin-7 inhibits STAGA histone acetyltransferase activity to produce retinal degeneration
VB Palhan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Huntingtin phosphorylation on serine 421 is significantly reduced in the striatum and by polyglutamine expansion in vivo
SC Warby et al.
HUMAN MOLECULAR GENETICS (2005)
Interference of CREB-dependent transcriptional activation by expanded polyglutamine stretches - augmentation of transcriptional activation as a potential therapeutic strategy for polyglutamine diseases
M Shimohata et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers
A Demuro et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
RNA interference improves motor and neuropathological abnormalities in a Huntington's disease mouse model
SQ Harper et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Co-chaperone CHIP associates with expanded polyglutamine protein and promotes their degradation by proteasomes
NR Jana et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Defective DNA single-strand break repair in spinocerebellar ataxia with axonal neuropathy-1
SF El-Khamisy et al.
NATURE (2005)
Neuronal dysfunction in a polyglutamine disease model occurs in the absence of ubiquitin-proteasome system impairment and inversely correlates with the degree of nuclear inclusion formation
AB Bowman et al.
HUMAN MOLECULAR GENETICS (2005)
Disturbed Ca2+ signaling and apoptosis of medium spiny neurons in Huntington's disease
TS Tang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Polyglutamine expansion diseases: failing to deliver
G Morfini et al.
TRENDS IN MOLECULAR MEDICINE (2005)
Modulation of neurodegeneration by molecular chaperones
PJ Muchowski et al.
NATURE REVIEWS NEUROSCIENCE (2005)
Eukaryotic proteasomes cannot digest polyglutamine sequences and release them during degradation of polyglutamine-containing proteins
P Venkatraman et al.
MOLECULAR CELL (2004)
Trehalose alleviates polyglutamine-mediated pathology in a mouse model of Huntington disease
M Tanaka et al.
NATURE MEDICINE (2004)
Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington's disease
JM Canals et al.
JOURNAL OF NEUROSCIENCE (2004)
RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia
HB Xia et al.
NATURE MEDICINE (2004)
Protein aggregation and neurodegenerative disease
CA Ross et al.
NATURE MEDICINE (2004)
Chemotherapy for the brain: The antitumor antibiotic mithramycin prolongs survival in a mouse model of Huntington's disease
RJ Ferrante et al.
JOURNAL OF NEUROSCIENCE (2004)
Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein misfolding diseases
R Kayed et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Polyglutamine repeats of spinocerebellar ataxia 6 impair the cell-death-preventing effect of Cav2.1 Ca2+ channel-loss-of-function cellular model of SCA6
Z Matsuyama et al.
NEUROBIOLOGY OF DISEASE (2004)
Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease
B Ravikumar et al.
NATURE GENETICS (2004)
Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death
M Arrasate et al.
NATURE (2004)
Caspase-mediated proteolysis of the polyglutamine disease protein ataxin-3
SJS Berke et al.
JOURNAL OF NEUROCHEMISTRY (2004)
CHIP activates HSF1 and confers protection against apoptosis and cellular stress
Q Dai et al.
EMBO JOURNAL (2003)
Regulation of cell death: The calcium-apoptosis link
S Orrenius et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2003)
Aberrant histone acetylation, altered transcription, and retinal degeneration in a Drosophila model of polyglutamine disease are rescued by CREB-binding protein
JP Taylor et al.
GENES & DEVELOPMENT (2003)
Prevention of polyglutamine oligomerization and neurodegeneration by the peptide inhibitor QBP1 in Drosophila
Y Nagai et al.
HUMAN MOLECULAR GENETICS (2003)
Leuprorelin rescues polyglutamine-dependent phenotypes in a transgenic mouse model of spinal and bulbar muscular atrophy
M Katsuno et al.
NATURE MEDICINE (2003)
Interaction of Akt-phosphorylated ataxin-1 with 14-3-3 mediates neurodegeneration in spinocerebellar ataxia type 1
HK Chen et al.
CELL (2003)
Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis
R Kayed et al.
SCIENCE (2003)
Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease
E Hockly et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Pivotal role of oligomerization in expanded polyglutamine neurodegenerative disorders
I Sánchez et al.
NATURE (2003)
Mutational analysis of the structural organization of polyglutamine aggregates
AK Thakur et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
SUMO-1 co-localized with mutant atrophin-1 with expanded polyglutamines accelerates intranuclear aggregation and cell death
T Terashima et al.
NEUROREPORT (2002)
DNA repair in neural cells: basic science and clinical implications
PJ Brooks
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2002)
Huntingtin spheroids and protofibrils as precursors in polyglutamine fibrilization
MA Poirier et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Polyglutamine and transcription: gene expression changes shared by DRPLA and Huntington's disease mouse models reveal context-independent effects
R Luthi-Carter et al.
HUMAN MOLECULAR GENETICS (2002)
Tauroursodeoxycholic acid, a bile acid, is neuroprotective in a transgenic model of Huntington's disease
CD Keene et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease
AW Dunah et al.
SCIENCE (2002)
The IGF-1/Akt pathway is neuroprotective in Huntington's disease and involves huntingtin phosphorylation by Akt
S Humbert et al.
DEVELOPMENTAL CELL (2002)
Partitioning of lipid-modified monomeric GFPs into membrane microdomains of live cells
DA Zacharias et al.
SCIENCE (2002)
Amyloid fibers are water-filled nanotubes
MF Perutz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Huntingtin inclusions do not deplete polyglutamine-containing transcription factors in HD mice
ZX Yu et al.
HUMAN MOLECULAR GENETICS (2002)
Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo
DM Walsh et al.
NATURE (2002)
Live-cell fluorescent biosensors for activated signaling proteins
K Hahn et al.
CURRENT OPINION IN CELL BIOLOGY (2002)
Intra- and intermolecular β-pleated sheet formation in glutamine-repeat inserted myoglobin as a model for polyglutamine diseases
M Tanaka et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Role and fate of PML nuclear bodies in response to interferon and viral infections
T Regad et al.
ONCOGENE (2001)
Caspase 3-cleaved N-terminal fragments of wild-type and mutant huntingtin are present in normal and Huntington's disease brains, associate with membranes, and undergo calpain-dependent proteolysis
YJ Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
An expanded glutamine repeat destabilizes native ataxin-3 structure and mediates parallel β-fibrils
AE Bevivino et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease
C Zuccato et al.
SCIENCE (2001)
Impairment of the ubiquitin-proteasome system by protein aggregation
NF Bence et al.
SCIENCE (2001)
Interference by Huntingtin and atrophin-1 with CBP-mediated transcription leading to cellular toxicity
FC Nucifora et al.
SCIENCE (2001)
Genetic suppression of polyglutamine toxicity in Drosophila
P Kazemi-Esfarjani et al.
SCIENCE (2000)
Expanded polyglutamine stretches interact with TAF(II)130, interfering with CREB-dependent transcription
T Shimohata et al.
NATURE GENETICS (2000)
Share Paper
